U.S. Food and Drug Administration for the first time approves vaccine for prevention of Ebola.
," Anna Abram, FDA deputy commissioner for policy, legislation, and international affairs, said in a statement Thursday."Today's approval is an important step in our continuing efforts to fight Ebola in close coordination with our partners across the U.S. Department of Health and Human Services, as well as our international partners, such as the World Health Organization."
The virus has an incubation period that ranges from 2 to 21 days. It's one of the most deadly viruses on the planet, with a fatality rate of 50 to 90 percent. A health worker fills a syringe with an Ebola vaccine before injecting it into a patient in Goma, Democratic Republic of Congo, Aug. 5, 2019.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves first-ever vaccine for prevention of Ebola virusThe US Food and Drug administration has approved for the first time in the United States a vaccine for the prevention of the deadly Ebola virus, the agency announced Thursday.
Consulte Mais informação »
Merck receives FDA approval for Ebola vaccineThe U.S. Food and Drug Administration said on Thursday it granted approval to dr...
Consulte Mais informação »
FDA targets e-cigs that hook teens but don't help smokers quitBy May, e-cigarette makers must submit applications to the FDA proving that their products provide a net benefit to public health.
Consulte Mais informação »
FDA grants accelerated approval for Astellas, Seattle Genetics' bladder cancer drugU.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma ...
Consulte Mais informação »
Special Report: FDA targets e-cigs that hook teens but don't help smokers quitE-cigarette makers face an existential threat. By May, they must submit applicat...
Consulte Mais informação »
Special Report: FDA targets e-cigs that hook teens but don't help smokers quitBy May, they must submit applications to the U.S. Food and Drug Administration proving that their products provide a net benefit to public health. If a company fails to make its case, the FDA has the power to order its products off the market. The data show that e-cigarettes are having little impact
Consulte Mais informação »